(1) As used in this subchapter:(1) “Charitable clinic” means a charitable nonprofit corporation or a facility organized as a not-for-profit corporation under §§ 4-28-201 — 4-28-206 and 4-28-209 — 4-28-224 that:(A) Holds a valid exemption from federal income taxation issued pursuant to section 501(a) of the Internal Revenue Code;(B) Is listed as an exempt organization under section 501(c)(3) of the Internal Revenue Code;(C) Provides advice, counseling, diagnosis, treatment, surgery, care, or services relating to the preservation or maintenance of health on an outpatient basis for a period of less than twenty-four (24) consecutive hours to persons not residing or confined at the facility;(D) May charge an administrative fee or request a donation not to exceed ten dollars ($10.00) per visit; and(E) Has a licensed outpatient pharmacy;(2) “Charitable clinic pharmacy” means the practice of a pharmacy at a site where prescriptions are dispensed by a charitable clinic free of charge to appropriately screened and qualified indigent patients;(3) “Controlled substances” means substances defined by the Uniform Controlled Substances Act, § 5-64-101 et seq.;(4) “Indigent” means a person with an income that is below two hundred percent (200%) of the federal poverty level;(5) “Nursing facility” means the same as under § 20-10-1401;(6) (A) (i) “Prescription drug” means a drug limited by section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., to being dispensed by or upon a medical practitioner's prescription because the drug is: (a) Habit-forming; (b) Toxic or having potential for harm; or (c) Limited in its use to use under a practitioner's supervision by the new drug application for the drug.(ii) The product label of a legend drug is required to contain the statement: (a) “CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT A PRESCRIPTION”; or (b) “Rx only”.(iii) The drug is subject to the requirement of section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., which shall be exempt from section 502(f)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., if certain specified conditions are met.(B) “Prescription drug” does not include controlled substances; and(7) “Properly transferred” means the storage, handling, and distribution of the drug under this subchapter in:(A) Accordance with the label; and(B) Its dispensed, sealed, tamper-evident single-user unit.
(1) “Charitable clinic” means a charitable nonprofit corporation or a facility organized as a not-for-profit corporation under §§ 4-28-201 — 4-28-206 and 4-28-209 — 4-28-224 that:(A) Holds a valid exemption from federal income taxation issued pursuant to section 501(a) of the Internal Revenue Code;(B) Is listed as an exempt organization under section 501(c)(3) of the Internal Revenue Code;(C) Provides advice, counseling, diagnosis, treatment, surgery, care, or services relating to the preservation or maintenance of health on an outpatient basis for a period of less than twenty-four (24) consecutive hours to persons not residing or confined at the facility;(D) May charge an administrative fee or request a donation not to exceed ten dollars ($10.00) per visit; and(E) Has a licensed outpatient pharmacy;
(A) Holds a valid exemption from federal income taxation issued pursuant to section 501(a) of the Internal Revenue Code;
(B) Is listed as an exempt organization under section 501(c)(3) of the Internal Revenue Code;
(C) Provides advice, counseling, diagnosis, treatment, surgery, care, or services relating to the preservation or maintenance of health on an outpatient basis for a period of less than twenty-four (24) consecutive hours to persons not residing or confined at the facility;
(D) May charge an administrative fee or request a donation not to exceed ten dollars ($10.00) per visit; and
(E) Has a licensed outpatient pharmacy;
(2) “Charitable clinic pharmacy” means the practice of a pharmacy at a site where prescriptions are dispensed by a charitable clinic free of charge to appropriately screened and qualified indigent patients;
(3) “Controlled substances” means substances defined by the Uniform Controlled Substances Act, § 5-64-101 et seq.;
(4) “Indigent” means a person with an income that is below two hundred percent (200%) of the federal poverty level;
(5) “Nursing facility” means the same as under § 20-10-1401;
(6) (A) (i) “Prescription drug” means a drug limited by section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., to being dispensed by or upon a medical practitioner's prescription because the drug is: (a) Habit-forming; (b) Toxic or having potential for harm; or (c) Limited in its use to use under a practitioner's supervision by the new drug application for the drug.(ii) The product label of a legend drug is required to contain the statement: (a) “CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT A PRESCRIPTION”; or (b) “Rx only”.(iii) The drug is subject to the requirement of section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., which shall be exempt from section 502(f)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., if certain specified conditions are met.(B) “Prescription drug” does not include controlled substances; and
(A) (i) “Prescription drug” means a drug limited by section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., to being dispensed by or upon a medical practitioner's prescription because the drug is: (a) Habit-forming; (b) Toxic or having potential for harm; or (c) Limited in its use to use under a practitioner's supervision by the new drug application for the drug.(ii) The product label of a legend drug is required to contain the statement: (a) “CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT A PRESCRIPTION”; or (b) “Rx only”.(iii) The drug is subject to the requirement of section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., which shall be exempt from section 502(f)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., if certain specified conditions are met.
(i) “Prescription drug” means a drug limited by section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., to being dispensed by or upon a medical practitioner's prescription because the drug is: (a) Habit-forming; (b) Toxic or having potential for harm; or (c) Limited in its use to use under a practitioner's supervision by the new drug application for the drug.
(a) Habit-forming;
(b) Toxic or having potential for harm; or
(c) Limited in its use to use under a practitioner's supervision by the new drug application for the drug.
(ii) The product label of a legend drug is required to contain the statement: (a) “CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT A PRESCRIPTION”; or (b) “Rx only”.
(a) “CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT A PRESCRIPTION”; or
(b) “Rx only”.
(iii) The drug is subject to the requirement of section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., which shall be exempt from section 502(f)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., if certain specified conditions are met.
(B) “Prescription drug” does not include controlled substances; and
(7) “Properly transferred” means the storage, handling, and distribution of the drug under this subchapter in:(A) Accordance with the label; and(B) Its dispensed, sealed, tamper-evident single-user unit.
(A) Accordance with the label; and
(B) Its dispensed, sealed, tamper-evident single-user unit.